Sleep and Cognitive Performance: Exploring Benzodiazepine Receptor Agonist Use, Insomnia Symptoms, and Obstructive Sleep Apnea

Abstract Objectives We hypothesized that benzodiazepine/z-drug (BZRA) dose, insomnia symptoms, and obstructive sleep apnea (OSA) risk are associated with cognitive performance above and beyond other modifiable dementia risk factors. Methods In this cross-sectional study, we used baseline data from recruited patients without dementia from one VA site and one academic site to analyze regression models based on previously published risk factors for cognitive impairment, adapted to include sleep and benzodiazepine usage interactions. Changes in R 2 and model fit (F-tests) were examined for four nested regression models predicting Mini-Mental State Examination (MMSE), Trail Making Test (TMT)-A, TMT-B, and Digit Symbol Substitution Test (DSST). Base Models included common dementia risk factors. Model-2 = Base + Insomnia Severity Index; Model-3 = Model-2 + dose; Model-4 = Model-3 + OSA risk; and Model-5 = Model-4 + OSA-BZRA. Results R 2 for the base model predicting MMSE was 0.139 (n = 313), 0.241 for TMT-A (n = 298), 0.229 for TMT-B (n = 287), and 0.189 for DSST (n = 285). Model-5 R 2 was 0.142 for MMSE, 0.246 for TMT-A, 0.238 for TMT-B, and 0.190 for DSST, with all F-test p-values >.145. Conclusions Sleep disorder variables did not significantly explain additional variation in cognition performance. Studies with a wider range of cognitive performance are needed.

Authors

Institutions

Publication Details

Journal
Ageing International
Published
2026-10-29
DOI
https://doi.org/10.1007/s12126-026-09684-6
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sleep and Cognitive Performance: Exploring Benzodiazepine Receptor Agonist Use, Insomnia Symptoms, and Obstructive Sleep Apnea

Joseph M. Dzierzewski, M. Safwan Badr, Cathy Alessi, Karen R Josephson et al.
1 links
Ageing International
Sleep and related disorders
article

Sleep and Cognitive Performance: Exploring Benzodiazepine Receptor Agonist Use, Insomnia Symptoms, and Obstructive Sleep Apnea

Joseph M. Dzierzewski, M. Safwan Badr, Cathy Alessi, Karen R Josephson, Constance H. Fung, Alison A. Moore, Lydia Ann, Michelle R. Zeidler, Erin Der‐Mcleod, Sara Ghadimi, Michael N. Mitchell, Saadia Naeem, Tue T. Te, Jennifer Martin
article en

Abstract

Abstract Objectives We hypothesized that benzodiazepine/z-drug (BZRA) dose, insomnia symptoms, and obstructive sleep apnea (OSA) risk are associated with cognitive performance above and beyond other modifiable dementia risk factors. Methods In this cross-sectional study, we used baseline data from recruited patients without dementia from one VA site and one academic site to analyze regression models based on previously published risk factors for cognitive impairment, adapted to include sleep and benzodiazepine usage interactions. Changes in R 2 and model fit (F-tests) were examined for four nested regression models predicting Mini-Mental State Examination (MMSE), Trail Making Test (TMT)-A, TMT-B, and Digit Symbol Substitution Test (DSST). Base Models included common dementia risk factors. Model-2 = Base + Insomnia Severity Index; Model-3 = Model-2 + dose; Model-4 = Model-3 + OSA risk; and Model-5 = Model-4 + OSA-BZRA. Results R 2 for the base model predicting MMSE was 0.139 (n = 313), 0.241 for TMT-A (n = 298), 0.229 for TMT-B (n = 287), and 0.189 for DSST (n = 285). Model-5 R 2 was 0.142 for MMSE, 0.246 for TMT-A, 0.238 for TMT-B, and 0.190 for DSST, with all F-test p-values >.145. Conclusions Sleep disorder variables did not significantly explain additional variation in cognition performance. Studies with a wider range of cognitive performance are needed.

Ageing InternationalVol. 51(4)
University of California, Los Angeles (US), Wayne State University (US), University of California, Irvine (US), University of California San Diego (US), John D. Dingell VA Medical Center (US), National Sleep Foundation (US), University of California, Irvine Medical Center (US), VA Greater Los Angeles Healthcare System (US)
U.S. Department of Veterans Affairs, John A. Hartford Foundation, National Sleep Foundation, Atlantic Philanthropies, Patient-Centered Outcomes Research Institute, Office of Research and Development, American Academy of Sleep Medicine, National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, Clinical and Translational Science Institute, University of California, Los Angeles
Good health and well-being
Openalex Percentile: Top 8%
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon